As India readies its own deep tech startup policy, this is episode three in a short series of conversations with some entrepreneurs and VC investors building this ecosystem. Today, Jogin Desai, founder and CEO of EyeStem Research, updates us on his company's effort to commercialise new therapeutics to combat degenerative eye diseases. Desai co-founded EyeStem in 2015, and the venture has raised about $10 million in funding so far. He also discusses some of the challenges of building a biotech venture in India